title: Pefloxacin as first-line treatment in nephrotic syndrome.
authors.forename: C
authors.initials: C
authors.lastname: Ginsburg
authors.forename: D
authors.initials: D
authors.lastname: Toledano
authors.forename: G
authors.initials: G
authors.lastname: Deray
authors.forename: D
authors.initials: D
authors.lastname: Vlassopoulos
authors.forename: A
authors.initials: A
authors.lastname: Baumelou
authors.forename: C
authors.initials: C
authors.lastname: Jacobs
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy; D006801:Humans; D008297:Male; D009402:Nephrosis, Lipoid / Q000188:drug therapy; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D015366:Pefloxacin / Q000627:therapeutic use*; D011507:Proteinuria / Q000188:drug therapy
chemical_list: D015366:Pefloxacin